Certified Global Research Member

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major playersâ€™ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

Narcolepsy Companies

Narcolepsy is a neurological disorder characterized by excessive daytime sleepiness, sudden and uncontrollable episodes of falling asleep, and disruptions in the sleep-wake cycle. While there are no specific companies dedicated solely to narcolepsy, there are pharmaceutical companies, research institutions, and healthcare organizations that focus on developing treatments, medications, and support services for individuals with narcolepsy.

Narcolepsy Market

Latest Narcolepsy Companies Updates:

Avadel's Xyrem® (sodium oxybate) Avadel received FDA approval for its Xyrem® chewable tablets, offering a new formulation of the existing sodium oxybate medication for cataplexy and excessive daytime sleepiness in narcolepsy patients.

Jazz Pharmaceuticals' Sunosi (solriamfetol) Positive results from a Phase 3 trial in June 2023 demonstrated the efficacy and safety of Sunosi in treating excessive daytime sleepiness associated with narcolepsy.

Takeda's TAK-994, an orexin 2 receptor agonist Phase 2 trial results presented in November 2023 showed promising potential for TAK-994 in improving cataplexy symptoms in narcolepsy patients.

List of Narcolepsy Key companies in the market:

Jazz Pharmaceuticals plc (Republic of Ireland)

BIOPROJET (Paris)

Ligand Pharmaceuticals, Inc. (U.S.)

Shire (Republic of Ireland)

Arena Pharmaceuticals, Inc. (U.S.)

Novartis AG (Switzerland)

Shionogi Inc. (U.S.)

Graymark Healthcare, Inc. (U.S.)

Mylan N.V. (U.S.)

Narcolepsy Market Highlights:

Narcolepsy Market Size

Narcolepsy Market Trends

Narcolepsy Market Analysis

Narcolepsy Market Share

Narcolepsy Market Highlights:

Narcolepsy Market Trends

Narcolepsy Market Analysis

Narcolepsy Market Share

Narcolepsy Companies

Leading companies partner with us for data-driven Insights

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.